Best Telehealth Clinics in Delaware (2026)

Delaware's telehealth framework is codified at Delaware Code Title 24, section 6002 (Authorization to practice by telehealth/telemedicine). SB 101 (signed July 2025) reconciled a conflict between the state's in-person exam requirement for controlled substances and its telehealth rules. The law now allows Schedule III through V medications for opioid use disorder treatment via telemedicine. Opioid prescribing via telemedicine is prohibited except for DSAMH-waived addiction treatment programs.

For non-opioid controlled substances like testosterone (Schedule III), Delaware permits telehealth prescribing without a mandatory in-person visit, following the federal DEA framework through December 2026.

Out-of-state providers need a separate Delaware controlled substance registration even if they hold compact or telehealth registration. This is an extra licensing hurdle that may deter some smaller telehealth platforms.

Delaware is an active IMLC member. Out-of-state physicians can obtain expedited Delaware licensure through the compact, but the separate controlled substance registration requirement adds an administrative step.

Delaware is a full practice authority state for nurse practitioners. NPs can prescribe independently, including controlled substances.

Delaware Medicaid covers GLP-1 receptor agonists for obesity — one of approximately 13 states with this Medicaid fee-for-service coverage as of January 2026. Prior authorization is required.

Delaware has no state sales tax — one of five states without one. The state has a progressive income tax with a top rate of 6.6%.

Delaware has 1.0 million residents. Provider availability is good, supported by IMLC membership, full NP practice authority, and Medicaid GLP-1 obesity coverage. The separate controlled substance registration may limit some smaller platforms.

All major TRT providers serve Delaware. Maximus ($100/mo), Hone Health ($25/mo), TRT Nation ($99/mo including DE), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available.

GLP-1 availability is unrestricted. All national GLP-1 providers serve Delaware. Medicaid covers GLP-1s for obesity with PA.

All HRT, hair loss, and ED providers with national coverage serve Delaware. No known provider exclusions.

TRT pricing: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Delaware Medicaid covers GLP-1s for obesity with PA — one of approximately 13 states with this coverage. Medicaid patients should verify PA criteria before paying out of pocket.

Delaware has no state sales tax. Prescription drugs are inherently untaxed. Delaware has a progressive income tax with a top rate of 6.6%.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

Delaware permits telehealth TRT prescribing without an in-person visit for non-opioid Schedule III substances. Out-of-state providers need a separate DE controlled substance registration. SB 101 (2025) reconciled telehealth and controlled substance rules. Full NP practice authority. Both compounded and FDA-approved testosterone available.

GLP-1 weight loss

No state-specific GLP-1 restrictions. Federal FDA compounding rules apply. Delaware Medicaid covers GLP-1s for obesity with PA — one of ~13 states with this coverage.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Delaware. No additional state restrictions.

Hair loss

Hair loss treatment follows standard federal prescribing rules. No additional state restrictions.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules. No additional state restrictions.

Peptides

Peptide therapy follows standard federal rules. The separate DE controlled substance registration applies to controlled peptides prescribed by out-of-state providers.